NZIER’s Shadow Board continues to favour further QE over a negative OCR
June 22, 2020
There remains a wide range of views amongst the Shadow Board on whether more monetary policy stimulus is required, and in what form. Overall, the consensus amongst the Shadow Board is that more stimulus would be required over the next twelve months, with the majority favouring an expa … Read more
COVID-19: The recovery ahead - NZIER Insight 88
June 18, 2020
New Zealand has managed the COVID-19 outbreak with relative success, in terms of containing infection rates and deaths. This has seen New Zealand move down alert levels over the past few weeks as we achieved zero active cases, with restrictions relaxed but the border closed. However, … Read more
NZIER Consensus Forecasts shows growth outlook highly uncertain
June 15, 2020
The latest NZIER Consensus Forecasts showed an even greater degree of uncertainty over the growth outlook ahead. With New Zealand having eliminated the number of active cases of COVID-19 and moving to Alert Level 1 on 8 June, focus now turns to keeping imported cases at bay on the lon … Read more
Better outcomes through increased access to physiotherapy
June 11, 2020
This report considers the opportunity of greater use of physiotherapy to contribute to better health and economic outcomes for those with low pain back pain, stroke, and osteoarthritis. These three conditions were selected as leading examples of the potential that physiotherapy could … Read more
Tourism beyond COVID-19 – is the future sustainable, local and green? NZIER Insight 87
June 9, 2020
The post-Covid Budget delivered some big numbers in offering support to help the economy recover from lockdown, but its effect still depends on how industry responds to government funded support. Much of the assistance seems aimed at restoring activity to its former levels, rather tha … Read more
A new generation medicines policy : Improved access and equity for New Zealanders
June 3, 2020
NZIER produced a discussion paper for Medicines New Zealand in order to look at what kinds of leadership, funding, services, workforce and technologies are needed to support optimal use of medicines for better health outcomes for New Zealanders. Read more